Fingerprint
Dive into the research topics of 'Dose-dependent effects of the once-daily GLP-1 receptor agonist lixisenatide in patients with Type 2 diabetes inadequately controlled with metformin: a randomized, double-blind, placebo-controlled trial'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically